EPISODE · Mar 12, 2026 · 23 MIN
628-多发性骨髓瘤CAR-T疗法的细胞图谱与成功因素
from 聊聊Sci
这份研究报告概述了BCMA靶向CAR T细胞疗法在治疗多发性骨髓瘤中的最新突破。研究人员通过构建单细胞图谱，深入解析了决定治疗成败与副作用的关键生物学特征。报告强调，CD4+ T细胞的杀伤能力和细胞的记忆状态，而非注射剂量，是预测长期疗效的核心因素。此外，文章重新定义了细胞耗竭的多维标准，并指出肿瘤微环境中的可溶性BCMA可作为监测病情的动态指标。这些发现不仅揭示了免疫治疗产生毒性的机制，也为未来通过精准制造和临床干预来优化疗效提供了重要指引。该研究预示着骨髓瘤治疗正迈向一个更加个体化且可能治愈的新阶段。References: Samur M K, Munshi N C. The cellular orchestra of CAR T success[J]. Cancer Cell, 2026.前往小宇宙评论区与主播互动
NOW PLAYING
628-多发性骨髓瘤CAR-T疗法的细胞图谱与成功因素
0:00
23:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 聊聊Sci?
This episode is 23 minutes long.
When was this 聊聊Sci episode published?
This episode was published on March 12, 2026.
What is this episode about?
这份研究报告概述了BCMA靶向CAR T细胞疗法在治疗多发性骨髓瘤中的最新突破。研究人员通过构建单细胞图谱，深入解析了决定治疗成败与副作用的关键生物学特征。报告强调，CD4+...
Can I download this 聊聊Sci episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!